Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.

@article{Gervaz2000GrowthIO,
  title={Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.},
  author={Pascal A Gervaz and Beatrix Scholl and Vivianne Padrun and Michel Gillet},
  journal={Liver},
  year={2000},
  volume={20 2},
  pages={108-13}
}
OBJECTIVE This study was undertaken in order to assess the efficacy of a potent angiogenesis inhibitor, TNP-470, on tumor growth in a syngeneic rodent model of liver metastases from colorectal cancer. BACKGROUND New blood vessel formation is a prerequisite for primary and metastatic tumor growth. TNP-470, a synthetic derivative of fumagillin when subcutaneously transplanted into nude mice, inhibits endothelial cell proliferation and migration, as well as the growth of various human cancers… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Inhibition of rat urinary bladder carcinogenesis by the antiangiogenic drug TNP-470.

Asian Pacific journal of cancer prevention : APJCP • 2006
View 2 Excerpts

Similar Papers

Loading similar papers…